Where I see patients (2)
Selected research
-
Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trial.
Lancet (London, England)
-
Hemoglobin Balkh, a Novel Mutation in Codon 132 of α2-Globin Gene [α132(H15) (+T) or HBA2:C.396dup (p.Val134fs)]: A Case Report and Insight into the Pathophysiology.
Hemoglobin
-
Disease burden, management strategies, and unmet needs in α-thalassemia due to hemoglobin H disease.
American journal of hematology
Contact me
Staff superheroes